SCHEDULE 13G

ESSA PHARMA INC

Common Shares, no par value per share · CUSIP: 29668H708

Event date: 2025-07-30

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares

Unavailable

Percent of class

Unavailable

• TANG CAPITAL MANAGEMENT, LLC

  Shares: 4,300,000.00 · Class: 9.7%

• KEVIN TANG

  Shares: 4,300,000.00 · Class: 9.7%

• TANG CAPITAL PARTNERS, LP

  Shares: 2,418,320.00 · Class: 5.5%

• TANG CAPITAL PARTNERS INTERNATIONAL, LP

  Shares: 1,881,680.00 · Class: 4.2%

• TANG CAPITAL PARTNERS III, INC

  Shares: 0.00 · Class: 0.0%

• TANG CAPITAL PARTNERS IV, INC

  Shares: 0.00 · Class: 0.0%

• CONCENTRA BIOSCIENCES, LLC

  Shares: 0.00 · Class: 0%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.